Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease
暂无分享,去创建一个
Stella-Rita C. Ibeawuchi | D. Sahoo | W. Sandborn | Soumita Das | P. Ghosh | G. Katkar | Courtney Tindle | MacKenzie Fuller | Y. Mittal | I. Sayed | Rama F. Pranadinata | Dominik L. Stec | John T. Chang | Lee Swanson
[1] Stella-Rita C. Ibeawuchi,et al. The stress polarity signaling (SPS) pathway serves as a marker and a target in the leaky gut barrier: implications in aging and cancer , 2020, Life Science Alliance.
[2] M. Murad,et al. First- and Second-line Pharmacotherapies for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis. , 2020, Clinical Gastroenterology and Hepatology.
[3] Wooseong Kim,et al. Mesalazine activates adenosine monophosphate-activated protein kinase: Implication in the anti-inflammatory activity of this anti-colitic drug. , 2019, Current molecular pharmacology.
[4] H. Morita,et al. Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4+ T cells through AMPK activation , 2019, Scientific Reports.
[5] S. Vermeire,et al. Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease , 2019, EBioMedicine.
[6] Qiang Xu,et al. Activating AMPK to Restore Tight Junction Assembly in Intestinal Epithelium and to Attenuate Experimental Colitis by Metformin , 2018, Front. Pharmacol..
[7] M. Du,et al. AMPK in regulation of apical junctions and barrier function of intestinal epithelium , 2018, Tissue barriers.
[8] Stella-Rita C. Ibeawuchi,et al. Dysregulation of the engulfment pathway in the gut fuels Inflammatory Bowel Disease , 2018, bioRxiv.
[9] D. Sahoo,et al. Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer , 2018, Oncotarget.
[10] C. Gelfi,et al. Contribution of Extracellular Matrix and Signal Mechanotransduction to Epithelial Cell Damage in Inflammatory Bowel Disease Patients: A Proteomic Study , 2017, Proteomics.
[11] Andrea Califano,et al. Systematic, network-based characterization of therapeutic target inhibitors , 2017, PLoS Comput. Biol..
[12] K. Hao,et al. A functional genomics predictive network model identifies regulators of inflammatory bowel disease , 2017, Nature Genetics.
[13] T. Phan,et al. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing. , 2017, Gastroenterology.
[14] Xinying Xu,et al. An Ameliorated Prediction of Drug–Target Interactions Based on Multi-Scale Discrete Wavelet Transform and Network Features , 2017, International journal of molecular sciences.
[15] Mei-Jun Zhu,et al. AMP-activated protein kinase: a therapeutic target in intestinal diseases , 2017, Open Biology.
[16] R. Kurumbail,et al. Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy , 2017, The Journal of Pharmacology and Experimental Therapeutics.
[17] M. Donowitz,et al. A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions , 2017, Scientific Reports.
[18] Ming Xu,et al. Geniposide ameliorates TNBS-induced experimental colitis in rats via reducing inflammatory cytokine release and restoring impaired intestinal barrier function , 2017, Acta Pharmacologica Sinica.
[19] M. Du,et al. AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression , 2017, Cell Death and Differentiation.
[20] Bo Wang,et al. Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results. , 2016, JAMA internal medicine.
[21] I. Kufareva,et al. AMP-activated protein kinase fortifies epithelial tight junctions during energetic stress via its effector GIV/Girdin , 2016, eLife.
[22] Damian Szklarczyk,et al. The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..
[23] P. Rutgeerts,et al. Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC , 2016, Gut.
[24] Jessica Ward,et al. Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy. , 2016, Journal of medicinal chemistry.
[25] Yansong Xue,et al. Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice , 2016, PloS one.
[26] J. Scannell,et al. When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis , 2016, PloS one.
[27] D. Sahoo,et al. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. , 2016, The New England journal of medicine.
[28] L. Eckmann,et al. Regulation of Rac1 and Reactive Oxygen Species Production in Response to Infection of Gastrointestinal Epithelia , 2016, PLoS pathogens.
[29] A. del Sol,et al. Prediction of disease–gene–drug relationships following a differential network analysis , 2016, Cell Death and Disease.
[30] R. Uwiera,et al. Animal models to study acute and chronic intestinal inflammation in mammals , 2015, Gut Pathogens.
[31] Isabelle Cleynen,et al. Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.
[32] Judy H. Cho,et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.
[33] Jinshui Fan,et al. Mobilization of epithelial mesenchymal transition genes distinguishes active from inactive lesional tissue in patients with ulcerative colitis. , 2015, Human molecular genetics.
[34] M. Bøgsted,et al. Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies , 2015, Inflammatory bowel diseases.
[35] M. Helmrath,et al. Establishment of Human Epithelial Enteroids and Colonoids from Whole Tissue and Biopsy , 2015, Journal of visualized experiments : JoVE.
[36] E. E. Vincent,et al. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. , 2015, Immunity.
[37] J. Florholmen. Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease , 2015, Scandinavian journal of gastroenterology.
[38] P. Rutgeerts,et al. Integrated miRNA and mRNA Expression Profiling in Inflamed Colon of Patients with Ulcerative Colitis , 2014, PloS one.
[39] Rainer Breitling,et al. TrypanoCyc: a community-led biochemical pathways database for Trypanosoma brucei , 2014, Nucleic Acids Res..
[40] Jung Mogg Kim,et al. Anti‐inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis‐associated colon cancer , 2014, Journal of gastroenterology and hepatology.
[41] B. Chassaing,et al. Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice , 2014, Current protocols in immunology.
[42] David Carling,et al. Structural basis of AMPK regulation by small molecule activators , 2013, Nature Communications.
[43] M. Ramanathan,et al. Network‐Based Approaches in Drug Discovery and Early Development , 2013, Clinical pharmacology and therapeutics.
[44] Henning Hermjakob,et al. The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..
[45] Hiroyuki Miyoshi,et al. In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture , 2013, Nature Protocols.
[46] W. Fries,et al. Sealing the broken barrier in IBD: intestinal permeability, epithelial cells and junctions. , 2013, Current drug targets.
[47] L. Tran,et al. Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.
[48] M. Westerhoff,et al. Gene Signature Distinguishes Patients with Chronic Ulcerative Colitis Harboring Remote Neoplastic Lesions , 2013, Inflammatory bowel diseases.
[49] Sean R. Davis,et al. NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..
[50] I. Jurisica,et al. Network-based characterization of drug-regulated genes, drug targets, and toxicity. , 2012, Methods.
[51] J. Ahluwalia. Immunotherapy in inflammatory bowel disease. , 2012, The Medical clinics of North America.
[52] D. Sahoo. The Power of Boolean Implication Networks , 2012, Front. Physio..
[53] Rachel B. Brem,et al. Stitching together Multiple Data Dimensions Reveals Interacting Metabolomic and Transcriptomic Networks That Modulate Cell Regulation , 2012, PLoS biology.
[54] W. Khan,et al. Investigating intestinal inflammation in DSS-induced model of IBD. , 2012, Journal of visualized experiments : JoVE.
[55] Jens-Peter Volkmer,et al. Three differentiation states risk-stratify bladder cancer into distinct subtypes , 2012, Proceedings of the National Academy of Sciences.
[56] R. Kiesslich,et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease , 2011, Gut.
[57] A. Barabasi,et al. Systems biology and the future of medicine , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.
[58] Pradeep S Rajendran,et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors , 2011, Nature Biotechnology.
[59] C. Bernstein,et al. AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis. , 2010, Biochemical pharmacology.
[60] Kristel Van Steen,et al. Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease‡ , 2010, Inflammatory bowel diseases.
[61] Debashis Sahoo,et al. MiDReG: A method of mining developmentally regulated genes using Boolean implications , 2010, Proceedings of the National Academy of Sciences.
[62] Isabelle Cleynen,et al. Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment , 2009, PloS one.
[63] B. Viollet,et al. AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol , 2009, Diabetes.
[64] Le Shen,et al. Mechanisms and Functional Implications of Intestinal Barrier Defects , 2009, Digestive Diseases.
[65] D. Sahoo,et al. Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. , 2009, Genes & development.
[66] H. Clevers,et al. Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche , 2009, Nature.
[67] S. Friend,et al. A network view of disease and compound screening , 2009, Nature Reviews Drug Discovery.
[68] Robert Tibshirani,et al. Boolean implication networks derived from large scale, whole genome microarray datasets , 2008, Genome Biology.
[69] M. Farquhar,et al. Activation of Gαi3 triggers cell migration via regulation of GIV , 2008, The Journal of cell biology.
[70] P. Csermely. Creative elements: network-based predictions of active centres in proteins and cellular and social networks. , 2008, Trends in biochemical sciences.
[71] Debashis Sahoo,et al. Extracting binary signals from microarray time-course data , 2007, Nucleic acids research.
[72] Dennis B. Troup,et al. NCBI GEO: mining tens of millions of expression profiles—database and tools update , 2006, Nucleic Acids Res..
[73] Adam A. Margolin,et al. Reverse engineering cellular networks , 2006, Nature Protocols.
[74] M. Farquhar,et al. Identification and Characterization of GIV, a Novel Gαi/s -interacting Protein Found on COPI, Endoplasmic Reticulum-Golgi Transport Vesicles* , 2005, Journal of Biological Chemistry.
[75] Shailesh V. Date,et al. A Probabilistic Functional Network of Yeast Genes , 2004, Science.
[76] E. Koonin,et al. Conservation and coevolution in the scale-free human gene coexpression network. , 2004, Molecular biology and evolution.
[77] Chris Wiggins,et al. ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.
[78] Laurent Beaugerie,et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.
[79] M. Reinders,et al. Genetic network modeling. , 2002, Pharmacogenomics.
[80] I S Kohane,et al. Mutual information relevance networks: functional genomic clustering using pairwise entropy measurements. , 1999, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.
[81] G. Corrao,et al. Intestinal permeability test as a predictor of clinical course in Crohn's disease , 1999, American Journal of Gastroenterology.
[82] J. Boudeau,et al. Invasive Ability of an Escherichia coliStrain Isolated from the Ileal Mucosa of a Patient with Crohn’s Disease , 1999, Infection and Immunity.
[83] G. Church,et al. Systematic determination of genetic network architecture , 1999, Nature Genetics.
[84] E. Szigethy,et al. Inflammatory bowel disease. , 2011, Pediatric clinics of North America.
[85] N. Gulbahce,et al. Network medicine: a network-based approach to human disease , 2010, Nature Reviews Genetics.
[86] Judy H Cho,et al. Inflammatory bowel disease. , 2009, The New England journal of medicine.
[87] G. Sumara,et al. A Probabilistic Functional Network of Yeast Genes , 2004 .
[88] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..